Article

Bristol-Myers Squibb to Take Part in Leerink Partners Inaugural Immuno-Oncology Roundtable Conference

Bristol-Myers Squibb will take part in Leerink Partners Immuno-Oncology Roundtable on October 1.

PRESS RELEASE

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, in New York. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about the company at 10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session athttp://investor.bms.com. An archived edition of the session will be available later that day.

Related Videos
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Senior Doctor is examining An Asian patient.
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com